Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the R:GEN Laser System as an Intervention in Subjects With Early Stages of Age Related Macular Degeneration (AMD) for Safety and Exploratory Efficacy Outcomes

NCT04776031 is registered in ClinicalTrials.gov with Lutronic Vision, Inc as lead sponsor.

NCT NCT04776031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04776031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the R:GEN Laser System as an Intervention in Subjects With Early Stages of Age Related Macular Degeneration (AMD) for Safety and Exploratory Efficacy Outcomes
Lead sponsor
Lutronic Vision, Inc
Phase
Not applicable
Overall status
Completed
Start date
February 15, 2021
Completion date
March 14, 2023
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early age related macular degeneration (disorder)